At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 90 enrolled
Drug / intervention
Buprenorphine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
In Brief
A Phase 2 clinical trial evaluating CBT, Buprenorphine, and 2 other interventions for Opiate Dependence and Chronic Pain. Completed, enrolled 90 participants across 1 site.
Detailed Summary
This study is designed to develop an effective psychotherapy for chronic pain and opioid dependence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpiate Dependence, Chronic Pain
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 2008
Enrollment StartSep 2009
Primary CompletionMay 2015
Study CompletionAug 2015
TodayJul 2026
First PostedMar 13, 2008
Enrollment StartSep 1, 2009
Primary CompletionMay 1, 2015
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 18.3 years ago
Interventions
CBTbehavioral
Cognitive behavioral therapy
Buprenorphinedrug
buprenorphine/naloxone
Educational Counselingother
Didactic, lecture-discussion format to supplement information and advice provided by physicians
Physician Managementother
Brief physician counseling